GLOSA LUB KOMENTARZ PRAWNICZY
Geny a białaczki dziecięce
Julita Kęsy 1 , Danuta Januszkiewicz-Lewandowska 21. Medical Biotechnology Student at Poznan University of Medical Sciences
2. Department of Paediatric Oncology, Haematology and Transplantology, Poznan University of Medical Sciences
Opublikowany: 2015-03-05
DOI: 10.5604/17322693.1142719
GICID: 01.3001.0009.6504
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2015; 69 : 302-308
Abstrakt
Przypisy
- 1. Apperley J.: CML in pregnancy and childhood. Best Pract. Res.Clin. Haematol., 2009; 22: 455-474
Google Scholar - 2. Armstrong S.A., Look A.T.: Molecular genetics of acute lymphoblasticleukemia. J. Clin. Oncol., 2005; 23: 6306-6315
Google Scholar - 3. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.,Gralnick H.R., Sultan C.: Proposed revised criteria for the classificationof acute myeloid leukemia. A report of the French-AmericanBritishCooperative Group. Ann. Intern. Med., 1985; 103: 620-625
Google Scholar - 4. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.,Gralnick H.R., Sultan C.: Proposals for the classification of the acuteleukaemias. French-American-British (FAB) co-operative group. Br.J. Haematol., 1976; 33: 451-458
Google Scholar - 5. Cauwelier B., Dastugue N., Cools J., Poppe B., Herens C., De PaepeA., Hagemeijer A., Speleman F.: Molecular cytogenetic study of 126unselected T-ALL cases reveals high incidence of TCRβ locus rearrangementsand putative new Tcell oncogenes. Leukemia, 2006;20: 1238-1244
Google Scholar - 6. Fathi A.T., Grant S., Karp J.E.: Exploiting cellular pathways to developnew treatment strategies for AML. Cancer Treat. Rev., 2010;36: 142-150
Google Scholar - 7. Fröhling S., Scholl C., Gilliland D.G., Levine R.L.: Genetics of myeloidmalignancies: pathogenetic and clinical implications. J. Clin.Oncol., 2005; 23: 6285-6295
Google Scholar - 8. Graux C., Cools J., Michaux L., Vandenberghe P., Hagemeijer A.:Cytogenetics and molecular genetics of T-cell acute lymphoblasticleukemia: from thymocyte to lymphoblast. Leukemia, 2006; 20:1496-1510
Google Scholar - 9. Greaves M.: Childhood leukaemia. BMJ, 2002; 324: 283-287
Google Scholar - 10. Harrison C.: New genetics and diagnosis of childhood B-cell precursoracute lymphoblastic leukemia. Pediatr. Rep., 2011; 3 (Suppl.2): e4
Google Scholar - 11. Harrison C.J.: Cytogenetics of paediatric and adolescent acutelymphoblastic leukaemia. Br. J. Haematol., 2009; 144: 147-156
Google Scholar - 12. Harrison C.J., Haas O., Harbott J., Biondi A., Stanulla M., Trka J.,Izraeli S., Biology and Diagnosis Committee of International BerlinFrankfürt-Münsterstudy group: Detection of prognistically relevantgenetic abnormalities in childhood B-cell precursor acute lymphoblasticleukaemia: recommendations from the Biology and DiagnosisCommittee of the International Berlin- Frankfürt-Münster studygroup. Br. J. Haematol., 2010; 151: 132-142
Google Scholar - 13. Hasle H., Niemeyer C.M., Chessells J.M., Baumann I., BennettJ.M., Kerndrup G., Head D.R.: A pediatric approach to the WHO classificationof myelodysplastic and myeloproliferative diseases. Leukemia,2003; 17: 277-282
Google Scholar - 14. Kaspers G.J., Zwaan C.M.: Pediatric acute myeloid leukemia:towards high-quality cure of all patients. Haematologica, 2007; 92:1519-1532
Google Scholar - 15. Kelly L.M., Gilliland D.G.: Genetics of myeloid leukemias. Annu.Rev. Genomics Hum. Genet., 2002; 3: 179-198
Google Scholar - 16. Kumar C.C.: Genetic abnormalities and challenges in the treatmentof acute myeloid leukemia. Genes Cancer, 2011; 2: 95-107
Google Scholar - 17. Locatelli F., Zecca M., Pession A., Maserati E., De Stefano P.,Severi F.: Myelodysplastic syndromes: the pediatric point of view.Haematologica, 1995; 80: 268-279
Google Scholar - 18. Manola K.N.: Cytogenetics of pediatric acute myeloid leukemia.Eur. J. Haematol., 2009; 83: 391-405
Google Scholar - 19. Martinez-Climent J.A.: Molecular cytogenetics of childhood hematologicalmalignancies. Leukemia, 1997; 11: 1999-2021
Google Scholar - 20. Mullighan C.G.: Genomic analysis of acute leukemia. Int. J. Lab.Hematol., 2009; 31: 384-397
Google Scholar - 21. Pui C.H., Carroll W.L., Meshinchi S., Arceci R.J.: Biology, risk stratification,and therapy of pediatric acute leukemias: an update. J. Clin.Oncol., 2011; 29: 551-565
Google Scholar - 22. Pui C.H., Robison L.L., Look A.T.: Acute lymphoblastic leukaemia.Lancet, 2008; 371: 1030-1043
Google Scholar - 23. Ren R.: Mechanisms of BCR-ABL in the pathogenesis of chronicmyelogenous leukaemia. Nat. Rev. Cancer, 2005; 5: 172-183
Google Scholar - 24. Roberts K.G., Mullighan C.G.: How new advances in genetic analysisare influencing the understanding and treatment of childhoodacute leukemia. Curr. Opin. Pediatr., 2011; 23: 34-40
Google Scholar - 25. Steensma D.P.: The changing classification of myelodysplasticsyndromes: what’s in a name? Hematology Am. Soc. Hematol. Educ.Program, 2009; 2009: 645-655
Google Scholar - 26. Szczepański T., Harrison C.J., van Dongen J.J.: Genetic aberrationsin paediatric acute leukemias and implications for management ofpatients. Lancet Oncol., 2010; 11: 880-889
Google Scholar - 27. Takahashi S.: Current findings for recurring mutations in acutemyeloid leukemia. J. Hematol. Oncol., 2011; 4: 36
Google Scholar - 28. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., BorowitzM.J., Porwit A., Harris N.L., Le Beau M.M., Hellström-Lindberg E.,Tefferi A., Bloomfield C.D.: The 2008 revision of the World HealthOrganization (WHO) classification of myeloid neoplasms and acuteleukemia: rationale and important changes. Blood, 2009; 114: 937-951
Google Scholar - 29. Zhang Z., Burrows P.D., Cooper M.D.: The molecular basis and biologicalsignificance of VH replacement. Immunol. Rev., 2004; 197: 231-242
Google Scholar